Abstract 140P
Background
The cell membrane of the trypanosomiasis-causing parasite Trypanosoma brucei is densely coated with 10 million copies of Variant Surface Glycoproteins (VSGs). VSG is highly immunogenic and can elicit a robust and long-lasting humoral immune response from the host organism.
Methods
Our laboratory has adapted the T. brucei coat into a uniquely powerful immunization platform (VSG-immunogen Array by Sortase Tagging) that has the capacity to elicit antibody responses against previously untargetable antigen classes. The antigens of interest are covalently coupled to the VSG proteins on the membrane by a sortase reaction. Sortase is a bacterial enzyme that can covalently link any polypeptides to each other, provided that they contain the sortase recognition peptides. We have engineered trypanosomes whose VSGs bear the N-terminal sortase recognition motif, and we generate antigens that display the cognate C-terminal motif. This platform has elicited high-affinity monoclonal antibodies against several immunogens of interest, including small molecules and peptides.
Results
A current obstacle in the treatment of many diseases is the difficulty of targeting proteins within the target cells. TCR-like monoclonal antibodies (TCR-like-mAbs) present a unique solution by targeting MHC receptors presenting such intracellular proteins. Currently, we are developing antibodies against intracellular protein targets that are presented on MHC after processing by the proteasome machinery, for example the MART-1 peptide. MART-1 is a protein expressed in metastatic melanoma cells. The protein is further processed by proteasome machinery, leading to a stretch of peptide from amino acids 27-35 (EAAGIGILTV) being presented on the cell surface via MHC class I.
Conclusions
To target peptides such as MART-1, we are using the VAST platform to elicit high-affinity TCR-like antibodies that can recognize peptides within the context of MHC, but in an MHC agnostic manner.
Legal entity responsible for the study
Panosome GmbH, Deutsches Krebsforschungszentrum.
Funding
Panosome GmbH.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
200P - A novel multi-organ on chip model for metastatic tumor biology understanding
Presenter: Elisabetta Palama
Session: Poster Display
201P - Role of aerobic exercise training on the mitochondrial metabolism and effector function of CD8+ tumor-infiltrating lymphocytes
Presenter: Janaina Vieira
Session: Poster Display
202P - Discovery of immunological cellular neighborhoods from protein markers in spatial tumor data
Presenter: Marcin Mozejko
Session: Poster Display
203P - Identification of High Confidence Candidate Markers for Macrophage Infiltrating Tumor Microenvironment through Single Cell Genomic Atlases
Presenter: Constance Ciaudo Beyer
Session: Poster Display
204P - Effect of STAT6 Inhibition as a Novel Strategy for Promoting the Induction of Potent and Stable Regulatory T Cells for Use in Colitis Therapy
Presenter: SONIA LEON-CABRERA
Session: Poster Display